Preclinical Study of (68)Ga-DOTATOC: Biodistribution Assessment in Syrian Rats and Evaluation of Absorbed Dose in Human Organs

OBJECTIVE(S): Gallium-68 DOTA-DPhe(1)-Tyr(3)-Octreotide ((68)Ga-DOTATOC) has been applied by several European centers for the treatment of a variety of human malignancies. Nevertheless, definitive dosimetric data are yet unavailable. According to the Society of Nuclear Medicine and Molecular Imaging...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Asia Ocean J Nucl Med Biol
Egile Nagusiak: Naderi, Mojdeh, Zolghadri, Samaneh, Yousefnia, Hassan, Ramazani, Ali, Jalilian, Amir Reza
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Asia Oceania Journal of Nuclear Medicine & Biology 2016
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4937676/
https://ncbi.nlm.nih.gov/pubmed/27904870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7508/aojnmb.2016.04.004
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak